Quince Therapeutics receives Nasdaq delisting notice for bid price non-compliance

Quince Therapeutics, Inc.

Received Nasdaq notice for non-compliance with $1.00 minimum bid price requirement.
Closing bid price below $1.00 for 34 consecutive trading days.
Has until December 17, 2024 to regain compliance by closing at $1.00 for 10 consecutive days.
May transfer to Nasdaq Capital Market for additional 180-day compliance period if eligible.
Company will monitor closing bid price; no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.